Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,268,447
-$15,522,302 QoQ
Shares Held
241,392
-92.3% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 626 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $1,287,408,532 across 15 Drug Manufacturers - General names. OGN ranks #11 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,085,383 | $581,119,768 | |
| 2 | AMGN |
Amgen Inc
|
1,128,681 | $408,717,963 | |
| 3 | LLY |
ELI LILLY & Co
|
81,240 | $97,441,701 | |
| 4 | AZN |
Astrazeneca PLC
|
329,087 | $62,401,476 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
409,174 | $51,695,043 | |
| 6 | ABBV |
AbbVie Inc.
|
198,249 | $49,887,378 | |
| 7 | JNJ |
Johnson & Johnson
|
34,909 | $8,865,838 | |
| 8 | PFE |
Pfizer Inc
|
330,300 | $7,953,624 |
All Filings in OGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,268,447 | 241,392 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,790,749 | 3,137,020 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,562,312 | 2,170,476 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,849,714 | 641,359 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,513,952 | 156,400 | Shares | Sole | 2025-08-14 | |
| 2023-03-31 | $223,440 | 9,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,414,135 | 122,239 | Shares | Sole | 2023-02-14 | |
| 2021-12-31 | $894,468 | 29,375 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $936,974 | 28,575 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,242,959 | 41,076 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||